Search research articles
Contact Us
Filters
Showing results (241-250 of 323) with videos related to
Page
of 33
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 13, 2026
Circulating tumor DNA dynamics in patients with liver-limited metastatic colorectal cancer resected after first-line systemic treatment
Roberto Moretto, Vittorio Studiale, Seung Won Hyun, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 15, 2021
RAS as a positive predictive biomarker: focus on lung and colorectal cancer patients
Umberto Malapelle, Francesco Passiglia, Chiara Cremolini, et al.
International Journal of Cancer
|
April 10, 2020
Investigating the concordance in molecular subtypes of primary colorectal tumors and their matched synchronous liver metastasis
Andreas Schlicker, Architha Ellappalayam, Ines J Beumer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 8, 2026
Upfront Modified FOLFOXIRI Plus Panitumumab for <i>RAS/BRAF</i> Wild-Type Metastatic Colorectal Cancer: Final Results of the Phase III TRIPLETE Study
Veronica Conca, Daniele Rossini, Carlotta Antoniotti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 6, 2023
An Immune-Related Gene Expression Signature Predicts Benefit from Adding Atezolizumab to FOLFOXIRI plus Bevacizumab in Metastatic Colorectal Cancer
Carlotta Antoniotti, Alessandra Boccaccino, Robert Seitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 12, 2024
Upfront Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Plus Bevacizumab With or Without Atezolizumab for Patients With Metastatic Colorectal Cancer: Updated and Overall Survival Results of the ATEZOTRIBE Study
Carlotta Antoniotti, Daniele Rossini, Filippo Pietrantonio, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 6, 2020
Health-related quality of life in patients with RAS wild-type metastatic colorectal cancer treated with panitumumab-based first-line treatment strategy: A pre-specified secondary analysis of the Valentino study
Alessandra Raimondi, Massimo Di Maio, Federica Morano, et al.
Nature
|
November 30, 2017
Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth
Giovanni Germano, Simona Lamba, Giuseppe Rospo, et al.
Future Oncology (London, England)
|
October 5, 2017
Selecting patients for gastrectomy in metastatic esophago-gastric cancer: clinics and pathology are not enough
Lorenzo Fornaro, Valentina Fanotto, Gianna Musettini, et al.
Clinical Colorectal Cancer
|
March 12, 2026
Consistency of Radiological Staging in Resectable Mismatch-Repair Proficient Colon Cancer: An Interobserver Agreement Study
Vincenzo Nasca, Gabriele Tinè, Marta Vaiani, et al.
Page
of 33
Search research articles
Search
Showing results (241-250 of 323) with videos related to
Sort By:
Page
of 33
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 13, 2026
Circulating tumor DNA dynamics in patients with liver-limited metastatic colorectal cancer resected after first-line systemic treatment
Roberto Moretto, Vittorio Studiale, Seung Won Hyun, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 15, 2021
RAS as a positive predictive biomarker: focus on lung and colorectal cancer patients
Umberto Malapelle, Francesco Passiglia, Chiara Cremolini, et al.
International Journal of Cancer
|
April 10, 2020
Investigating the concordance in molecular subtypes of primary colorectal tumors and their matched synchronous liver metastasis
Andreas Schlicker, Architha Ellappalayam, Ines J Beumer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 8, 2026
Upfront Modified FOLFOXIRI Plus Panitumumab for <i>RAS/BRAF</i> Wild-Type Metastatic Colorectal Cancer: Final Results of the Phase III TRIPLETE Study
Veronica Conca, Daniele Rossini, Carlotta Antoniotti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 6, 2023
An Immune-Related Gene Expression Signature Predicts Benefit from Adding Atezolizumab to FOLFOXIRI plus Bevacizumab in Metastatic Colorectal Cancer
Carlotta Antoniotti, Alessandra Boccaccino, Robert Seitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 12, 2024
Upfront Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Plus Bevacizumab With or Without Atezolizumab for Patients With Metastatic Colorectal Cancer: Updated and Overall Survival Results of the ATEZOTRIBE Study
Carlotta Antoniotti, Daniele Rossini, Filippo Pietrantonio, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 6, 2020
Health-related quality of life in patients with RAS wild-type metastatic colorectal cancer treated with panitumumab-based first-line treatment strategy: A pre-specified secondary analysis of the Valentino study
Alessandra Raimondi, Massimo Di Maio, Federica Morano, et al.
Nature
|
November 30, 2017
Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth
Giovanni Germano, Simona Lamba, Giuseppe Rospo, et al.
Future Oncology (London, England)
|
October 5, 2017
Selecting patients for gastrectomy in metastatic esophago-gastric cancer: clinics and pathology are not enough
Lorenzo Fornaro, Valentina Fanotto, Gianna Musettini, et al.
Clinical Colorectal Cancer
|
March 12, 2026
Consistency of Radiological Staging in Resectable Mismatch-Repair Proficient Colon Cancer: An Interobserver Agreement Study
Vincenzo Nasca, Gabriele Tinè, Marta Vaiani, et al.
Page
of 33